Faecal tests in the early detection of colorectal cancer

Joanna Kowalik

doi:10.5114/pg.2020.98541

eISSN: 1897-4317
ISSN: 1895-5770

Gastroenterology Review/Przegląd Gastroenterologiczny

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

3/2020
vol. 15

Send email

Copy url:

abstract:

Review paper

Faecal tests in the early detection of colorectal cancer

Joanna Kowalik

¹

Diagnostic Laboratory of The Bonifratri Order Hospital of Saint John Grande, Krakow, Poland

Gastroenterology Rev 2020; 15 (3): 200–206

DOI: https://doi.org/10.5114/pg.2020.98541

Online publish date: 2020/09/19

View full text Get citation

PlumX metrics:

Colorectal cancer is one of the most common cancers in the world. It is the second most common cause of cancer deaths in both genders in Poland. Screening tests allow for early cancer detection, resulting in reduced mortality and better prognosis. Tests include a stool test for occult blood, checking for biomarkers in faeces, and stool DNA testing. Colonoscopy remains the gold standard in the diagnosis of cancer, both in Poland and around the world. To convince patients of the importance of such testing, it is necessary to have a wider knowledge of all the available diagnostic tests, to understand their advantages and disadvantages. This article will give descriptions of the respective tests and compare their effectiveness in the diagnosis of colorectal cancer.

keywords:

Faecal tests in the early detection of colorectal cancer

Joanna Kowalik 1

colorectal cancer, denoamas, screening, faecal occult blood test, Cologuard, M2-type pyruvate kinase

Joanna Kowalik

¹